Poll Results: California Proposed Drug Pricing Law (SB 17)
The key findings outlined in this report were drawn from a telephone survey of 1,023 California adults conducted August 4-9, 2017. A complete description of
The key findings outlined in this report were drawn from a telephone survey of 1,023 California adults conducted August 4-9, 2017. A complete description of
Make it your mission to hear this best-selling author and former leader of SEAL Team Six. Register for Access! 2018 on Feb 12-14 in Orlando,
Compelling and informative speakers provide critical industry information. Register for Access! 2018 on Feb 12-14 in Orlando, Florida: https://accessiblemeds.org/Access2018
Get up-to-the-minute information about changes in the generic and biosimilars industry. #Access2018 Register for Access! 2018 on Feb 12-14 in Orlando, Florida: https://accessiblemeds.org/Access2018
This is the networking opportunity of the year. Bring plenty of business cards. Register for Access! 2018 on Feb 12-14 in Orlando, Florida: https://accessiblemeds.org/Access2018
Access! 2018 is the only event of its kind, gathering industry leaders together to explore our new world—the business, the science, the technology, and the
Abusing the patent and regulatory systems to prolong a brand drug’s monopoly— a practice commonly referred to as “evergreening”— is increasingly being used as a
Everyone supports finding ways to address skyrocketing prescription drug prices that seem to keep going up year after year. Unfortunately, SB 5995 doesn’t address that
Bobby L is a 23-year-old physics major at Frostburg State University in Maryland. On top of his studies, he is an active participant in the
Association for Accessible Medicines files comments with FTC addressing buyer consolidation and anti-competitive tactics “Today AAM is calling on the FTC and other federal agencies
AAM’s Fall Tech Conference November 6 and 7 focused on Abbreviated New Drug Application (ANDA) review, GDUFA II enhancements, drug pricing, bioequivalence and data integrity
New digital course takes a population-level approach to curbing prescription drug abuse WASHINGTON DC – On Thursday, November 16, 2017, the Association for Accessible Medicines (AAM)
